Esopam

Esopam

escitalopram

Manufacturer:

Unison

Distributor:

Medline

Marketer:

Medline
Concise Prescribing Info
Contents
Escitalopram oxalate
Indications/Uses
Major depressive disorder, generalized & social anxiety disorder. Panic & obsessive-compulsive disorder.
Dosage/Direction for Use
Major depressive disorder, generalized anxiety disorder, obsessive-compulsive disorder, & panic disorder Adult Initially 10 mg once daily, may be increased to 20 mg once daily at least 1 wk, >18 yr Initially 10 mg once daily, may be increased to 20 mg once daily after at least 3 wk. Elderly 10 mg once daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Concomitant use w/ pimozole, or w/in 2 wk of MAOIs.
Special Precautions
Severe renal impairment. Closely monitor patients for clinical worsening, suicidality, or unusual changes in behavior during initial 1-2 mth of therapy. Discontinue if worsening of depression & symptoms occurs. History of seizure disorder or condition predisposing to seizures. Hyponatremia (increased in elderly). Exacerbation of sexual dysfunction. Concomitant use w/ CNS depressants, aspirin, NSAIDs, warfarin or anticoagulants. Patients w/ known bleeding tendencies. Pregnancy & lactation. Childn 12 yr (not FDA approved).
Adverse Reactions
Somnolence, insomnia; nausea; ejaculation disorder. Fatigue, dizziness, abnormal dreaming, lethargy, yawn; anorgasmia, menstrual disorder; xerostomia, diarrhea, constipation, decreased appetite, indigestion, vomiting, abdominal pain; impotence; neck/shoulder pain, paresthesia; rhinitis, sinusitis.
Drug Interactions
Increase effect/toxicity of alcohol, α/β-blockers, anticoagulants, antiplatelet, QT prolong agent, serotonin modulators, thrombolytic agents. Increased level/effects by alfuzosin, analgesic, cimetidine, ciprofloxacin. Decrease effect of iobenguane l 123. Decrease level/effects by carbamazepine, strong CYP 2C19 & CYP 3A4 inducers. Drodendarone, MAOIs; CYP2C19 & CYP3A4 inhibitors, cyproheptadine.
MIMS Class
Antidepressants
ATC Classification
N06AB10 - escitalopram ; Belongs to the class of selective serotonin reuptake inhibitors. Used in the management of depression.
Presentation/Packing
Form
Esopam FC tab 10 mg
Packing/Price
4 × 7's
Form
Esopam FC tab 20 mg
Packing/Price
4 × 7's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in